Tech Company Financing Transactions

PathologyWatch Funding Round

PathologyWatch closed a $2 million Series A funding round on 12/21/2020. Investors included Beni Venture Capital, BioVentures Investors and Lateral Capital.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series A
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Medical Devices & Instruments
Mailing Address
166 East 5900 South B104
Salt Lake City, UT 84107
Email Address
PathologyWatch is working with clinical dermatology practices like yours to manage your pathology workflow using a digital model. This helps to improve the quality of patient care, reduce costs, and open up new potential steams of revenue for clinics and hospitals.
PathologyWatch LinkedIn Company Profile
Social Media
PathologyWatch Company Twitter Account
Company News
PathologyWatch News
PathologyWatch on Facebook
PathologyWatch on YouTube

Management Team

Email & Social
Chief Executive Officer
Daniel Lambert
  Daniel Lambert LinkedIn Profile  Daniel Lambert Twitter Account  Daniel Lambert News  Daniel Lambert on Facebook
Chief Medical Officer
Gregory Osmond
  Gregory Osmond LinkedIn Profile  Gregory Osmond Twitter Account  Gregory Osmond News  Gregory Osmond on Facebook
VP - Bus. Development
Michael Torno
  Michael Torno LinkedIn Profile  Michael Torno Twitter Account  Michael Torno News  Michael Torno on Facebook



Browse more venture capital transactions:

Prev: 12/21/2020: Octave Bioscience venture capital transaction
Next: 12/21/2020: H1 venture capital transaction


Share this article


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC transactions reported here come from company press releases and news coverage. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary